In which condition oral pills should not be given to a woman?

RRB Nsg. Superintendent 21 July 2019 (shift 1st)

Pharmacology

Easy

Appeared in: RRB Nsg. Superintendent 21 July 2019 (shift 1st)

Explanation

Oral contraceptive pills (OCPs), particularly combined hormonal contraceptives containing estrogen, are contraindicated in women with hypertension.
The estrogen component can increase blood pressure by stimulating the renin-angiotensin system, leading to sodium and water retention.
Using OCPs in hypertensive women significantly elevates the risk of serious cardiovascular events, including stroke, myocardial infarction (heart attack), and venous thromboembolism.
The World Health Organization (WHO) considers severe hypertension an absolute contraindication (Category 4) for combined OCP use.

Option A: Vaginal infections are not a systemic contraindication for OCP use. While hormonal changes can sometimes alter vaginal flora, it does not prevent the safe use of the medication.
Option B: Asthma is a respiratory condition and is not considered a contraindication for the use of oral contraceptive pills.
Option D: This is often an indication for OCP use, not a contraindication. OCPs are frequently prescribed to regulate cycles, reduce heavy bleeding (menorrhagia), and alleviate painful periods (dysmenorrhea).

Visual 1: Flowchart: Mechanism of how OCPs increase blood pressure (Estrogen -> Liver -> Angiotensinogen -> Renin -> Angiotensin I -> ACE -> Angiotensin II -> Aldosterone -> Na+/Water Retention -> Increased BP).
Visual 2: Table: WHO Medical Eligibility Criteria for Contraceptive Use, highlighting Category 3 and 4 conditions for combined oral contraceptives.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Contraindications for Oral Contraceptive Pills (OCPs) as background academic context rather than a clinical decision trigger.
Nurses must conduct a thorough health history, including blood pressure measurement, before a patient starts OCPs and monitor it regularly during follow-up visits.
Patient education is critical. Nurses should teach patients about the signs and symptoms of hypertension and thromboembolism (e.g., severe headache, chest pain, shortness of breath, leg pain/swelling) and when to seek immediate medical attention.
What if? If a patient has well-controlled hypertension and wishes to use hormonal contraception, a progestin-only pill ('mini-pill') or other progestin-only methods (like an IUD or implant) may be a safer alternative as they have less impact on blood pressure.

How to Approach the Question

First, identify the core of the question: it asks for a contraindication, which is a reason not to use a medication.
The medication is 'oral pills,' which in a women's health context usually refers to oral contraceptives.
Evaluate each option against your knowledge of OCPs. Think about the hormonal effects of OCPs, particularly estrogen.
Recall that estrogen has known effects on the cardiovascular system, including blood pressure regulation and blood clotting.
Consider each option: A) Vaginal infection is a local issue. B) Asthma is a respiratory condition. C) Hypertension is a cardiovascular condition directly impacted by the hormonal effects of OCPs. D) Menstrual problems are often treated by OCPs.
Based on the known cardiovascular side effects of estrogen, hypertension is the most significant contraindication among the choices.

Concept Tested & Keywords

Q9f-QiVEL1IF2kDHzbz59g